ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 124 filers reported holding ANAPTYSBIO INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,907,298 | -87.9% | 106,197 | -86.3% | 0.01% | -87.9% |
| Q2 2023 | $15,782,294 | -6.5% | 775,924 | 0.0% | 0.09% | -1.1% |
| Q1 2023 | $16,884,106 | -29.8% | 775,924 | 0.0% | 0.09% | -36.1% |
| Q4 2022 | $24,045,885 | +120.7% | 775,924 | +81.6% | 0.14% | +102.8% |
| Q3 2022 | $10,897,000 | +25.7% | 427,179 | 0.0% | 0.07% | +44.9% |
| Q2 2022 | $8,672,000 | -17.9% | 427,179 | 0.0% | 0.05% | -19.7% |
| Q1 2022 | $10,568,000 | -28.8% | 427,179 | 0.0% | 0.06% | -15.3% |
| Q4 2021 | $14,844,000 | +28.1% | 427,179 | 0.0% | 0.07% | +41.2% |
| Q3 2021 | $11,585,000 | +4.6% | 427,179 | 0.0% | 0.05% | +4.1% |
| Q2 2021 | $11,077,000 | +20.3% | 427,179 | 0.0% | 0.05% | +22.5% |
| Q1 2021 | $9,206,000 | +0.2% | 427,179 | 0.0% | 0.04% | +14.3% |
| Q4 2020 | $9,184,000 | +27.8% | 427,179 | -12.3% | 0.04% | +20.7% |
| Q3 2020 | $7,187,000 | -37.4% | 487,243 | -5.1% | 0.03% | -43.1% |
| Q2 2020 | $11,476,000 | +246.2% | 513,677 | +119.0% | 0.05% | +155.0% |
| Q1 2020 | $3,315,000 | +80.4% | 234,592 | +107.4% | 0.02% | +100.0% |
| Q4 2019 | $1,838,000 | -53.6% | 113,086 | 0.0% | 0.01% | -63.0% |
| Q3 2019 | $3,957,000 | -38.0% | 113,086 | 0.0% | 0.03% | -37.2% |
| Q2 2019 | $6,380,000 | -22.8% | 113,086 | 0.0% | 0.04% | -18.9% |
| Q1 2019 | $8,261,000 | +14.5% | 113,086 | 0.0% | 0.05% | -10.2% |
| Q4 2018 | $7,214,000 | -36.1% | 113,086 | 0.0% | 0.06% | -20.3% |
| Q3 2018 | $11,283,000 | +117.3% | 113,086 | +54.7% | 0.07% | +89.7% |
| Q2 2018 | $5,192,000 | -45.2% | 73,086 | -19.8% | 0.04% | -51.2% |
| Q1 2018 | $9,480,000 | -48.1% | 91,086 | -49.8% | 0.08% | -49.4% |
| Q4 2017 | $18,269,000 | +369.3% | 181,386 | +62.8% | 0.16% | +393.8% |
| Q3 2017 | $3,893,000 | +38.8% | 111,386 | -5.0% | 0.03% | +28.0% |
| Q2 2017 | $2,805,000 | -32.6% | 117,211 | -21.9% | 0.02% | -26.5% |
| Q1 2017 | $4,163,000 | – | 150,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |